Buy BPC-157 Capsules in Australia
Buy BPC-157 capsules in Australia from Macropus Peptides: one bottle of 60 capsules, each holding 500 micrograms of the peptide, for 30 milligrams in total. BPC-157 is a 15 amino acid research peptide derived from a protective protein in gastric juice, and it is unusual among peptides in being reported as stable in stomach acid, which is why rodent studies have so often given it by mouth. The capsule format arrives pre-portioned and dry, so there is nothing to reconstitute and no diluent to buy. Every bottle is labelled with compound, amount per capsule, capsule count and lot number, and a certificate of analysis is available for each lot. The bottle holds three times the peptide of our 10mg vial and is priced below it. Order BPC-157 capsules online and your parcel is sent from inside Australia to any Australian address. For laboratory research only, sold to buyers aged 18 and over, not for human or veterinary use.
| Compound | BPC-157 capsules |
|---|---|
| Amount | 60 × 500 mcg |
| Form | Capsules |
| Category | Recovery research |
| Storage | See label |
| Testing | HPLC purity 98% or higher and mass spectrometry identity, every batch |
| Certificate of analysis | Available for every lot, matched to the lot number on the label |
Buy BPC-157 Capsules Australia: 60 x 500mcg Research Capsules
Macropus Peptides offers the gastric pentadecapeptide as a capsule product as well as a freeze-dried vial. Each bottle contains 60 capsules of 500 micrograms, a total of 30 milligrams, measured out at manufacture so the laboratory receives identical, ready-portioned units. One controlled source supplies both the capsules and the powder, and batches are traced by the lot code on each bottle.
BPC-157 capsules Australia: what the peptide is
BPC stands for body protection compound, a larger protein isolated from human gastric juice, and the research peptide is a 15-residue partial sequence of it. The synthetic chain reads Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val and weighs about 1,419 daltons. A Croatian research group first described it in the early 1990s, and it has since been examined in hundreds of rodent and cell studies. It remains a preclinical compound: no medicines regulator has approved it in any form, and controlled human data are scarce. The capsules contain exactly the same peptide as our vial, simply portioned dry into identical units.
How BPC-157 works in research
Three mechanisms recur across the literature. The first is growth and migration of tendon fibroblasts through focal adhesion kinase and paxillin signalling. The second is new blood vessel formation linked to the VEGFR2 receptor, and the third is interaction with the nitric oxide system. Researchers therefore use it to study angiogenesis, fibroblast behaviour and gut lining models in rodents and cultured cells. What sets it apart from most peptides is its reported stability in gastric juice, where short chains are usually broken down quickly. That property is why oral delivery has been part of its animal record from the start, and it is the scientific basis for a solid, capsule-form research product.
BPC-157 research: what the rodent studies show
Much of the published work is in rats and mice, and a large share of those studies gave the peptide in drinking water rather than by injection, making the oral route one of the best documented for this compound. Landmarks include transected Achilles tendon work in rats (Journal of Orthopaedic Research, 2003), fibroblast migration (Journal of Applied Physiology, 2011) and VEGFR2-linked vessel growth (Journal of Molecular Medicine, 2017). Gut and musculoskeletal findings were drawn together by Current Pharmaceutical Design in a 2018 review. Controlled human studies remain scarce. The full list, with designs and endpoints, is in our BPC-157 research studies library.
BPC-157 capsules specifications: the 60 count bottle
| Specification | Detail |
|---|---|
| Compound | BPC-157 capsules |
| Amount | 60 × 500 mcg |
| Form | Capsules |
| Category | Recovery research |
| Storage | See label |
One capsule contains 500 micrograms (0.5 mg) of peptide, and sixty make 30 mg per bottle. Because every unit carries the same amount, counts convert straight into mass: ten capsules equal 5 mg and twenty equal 10 mg, with no weighing. The screw-top bottle's printed label gives the compound, the fill per capsule, the count and the lot number. The certificate of analysis for that lot confirms peptide content, and we send it when you quote the number on the bottle.
BPC-157 capsules price in Australia
| Option | Price |
|---|---|
| BPC-157 capsules | $89.99 |
Each bottle has one Australian dollar price and ships once ordered. It holds 30 mg against the 10 mg in our priced vial, yet it costs less than that single vial, so on a per milligram basis the capsules are the cheaper way to buy the compound.
BPC-157 capsules or the 10mg vial: which to buy
Capsules suit groups that want dry, pre-measured units with no reconstitution, no bacteriostatic water and no cold chain for a made-up solution, and groups whose animal work follows the oral route documented in the literature. In mass terms a single bottle equals three 10mg vials, which helps a long study stay on one lot. The BPC-157 10mg vial remains the choice when a study needs the peptide in solution at a chosen concentration, as in cell culture, where a capsule shell would only get in the way. Many laboratories keep both on hand.
Where to buy BPC-157 Capsules in Australia
- Sold online at macropuspeptides.com, priced at $89.99
- Every batch HPLC tested to 98% or higher purity, with identity confirmed by mass spectrometry
- A certificate of analysis for every lot, matched to the lot number printed on the label
- Same-day dispatch from Australian stock for orders paid before 2pm AEST on a business day
- Tracked delivery Australia wide: standard in 2 to 5 working days, express in 1 to 2 working days
- Payment by PayID or bank transfer, with your order ID as the reference
How to get BPC-157 capsules: ordering online
- Add the 60 capsule bottle to your cart
- Choose how many bottles the study needs, ideally all from one lot
- Add the 10mg vial if you also run solution-based assays
- Finish payment, noting that the order is for adult research use
- Request the batch certificate once your order arrives
Storing BPC-157 capsules: no mixing step to manage
Dry peptide keeps far better than dissolved peptide, which is the main practical advantage of the format. Nothing is reconstituted, so there is no mixing date to record, no diluent to buy and no refrigerated solution with a limited life. Leave the capsules in the original bottle with the lid closed, since moisture is the chief threat to a dry product, and keep the bottle in a cool cupboard or a refrigerator as the label directs. Avoid decanting units into open trays on the bench. Write the lot code beside each experiment in your records, so any result can be matched to its paperwork.
Is BPC-157 available in Australia
Yes, as a research compound only. The ARTG lists no BPC-157 goods, and the TGA has approved it in no form, capsule or vial, which rules out selling it as a supplement or medicine, or giving it to humans or animals. It also appears on the World Anti-Doping Agency prohibited list. Scheduling sits with the Poisons Standard, so read the entry that governs your lab before placing an order.
BPC-157 capsules for sale Australia wide
Bottles are dispatched from Australian stock to every state and territory, whether the address is in Perth, Hobart or a country town. For a second oral-format peptide, see KPV capsules, and for comparison work add TB-500. Everything else is in our recovery research range.
References
- Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. Journal of Orthopaedic Research. 2003.
- The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology. 2011.
- Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of Molecular Medicine. 2017.
- BPC 157 and standard angiogenic growth factors. Gastrointestinal tract healing, lessons from tendon, ligament, muscle and bone healing. Current Pharmaceutical Design. 2018.
Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.